Curis | CRIS - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Bristol-Myers Squibb USD 8.41B 381M 2025-12
CSL USD 4.46B 2.71B 2025-12
Curis USD 1.14M 8.86M 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Incyte USD 1.17B 217.51M 2026-03
Merck USD 10.85B 2.57B 2025-12
Novartis USD 10.07B 184M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.45B 1.31B 2025-12
Takeda JPY 688.84B 101.71B 2026-03
TG Therapeutics USD 171.41M 16.98M 2026-03
Verastem USD 14.64M 14.1M 2025-12